Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2

Kidney Int. 2021 Sep;100(3):700-702. doi: 10.1016/j.kint.2021.07.002. Epub 2021 Jul 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing*
  • Antibody Formation
  • BNT162 Vaccine
  • COVID-19 Vaccines
  • Humans
  • Renal Dialysis* / adverse effects
  • Vaccination / adverse effects

Substances

  • Antibodies, Neutralizing
  • COVID-19 Vaccines
  • BNT162 Vaccine